| 4-Hydroxybenzoic acid derivatives as HDAC6-specific inhibitors modulating microtubular structure and HSP90α chaperone activity against prostate cancer C Seidel, M Schnekenburger, A Mazumder, MH Teiten, G Kirsch, M Dicato, ... Biochemical pharmacology 99, 31-52, 2016 | 96 | 2016 |
| Aberrant cytoplasmic localization of MLH1 characterizes a sub-clonal breast cancer cell population that seeds recurrence A Mazumder, JT DeWitt, E Oropeza, N Punturi, D Lozano, ... bioRxiv, 2024.02. 27.582389, 2024 | 1 | 2024 |
| Abstract A015: Mutations in mismatch repair genes that alter subcellular localization of the protein predict resistance to standard therapy but response to cell cycle inhibitors A Mazumder, S Haricharan Cancer Research 84 (3_Supplement_1), A015-A015, 2024 | | 2024 |
| Abstract P3-10-02: Cell cycle dysregulation in breast cancer: why the details matter S Seker, E Oropeza, S Carrel, A Mazumder, N Punturi, J Lei, M Anurag, ... Cancer Research 83 (5_Supplement), P3-10-02-P3-10-02, 2023 | | 2023 |
| Abstract P3-14-03: The DNA damage repair landscape in Black women with breast cancer A Mazumder, A Jimenez, RE Ellsworth, S George, SJ Freedland, ... Cancer Research 82 (4_Supplement), P3-14-03-P3-14-03, 2022 | | 2022 |
| Abstract PD8-05: Mismatch repair deficiency predicts response to HER2 blockade in HER2-negative breast cancer S Haricharan, N Punturi, S Seker, V Devarakonda, R Kalra, CH Chen, ... Cancer Research 81 (4_Supplement), PD8-05-PD8-05, 2021 | | 2021 |
| Abstract PO-090: Coordinate dysregulation of base excision repair and homologous recombination pathways predominates in ER+/HER2-breast tumors from African American patients … A Mazumder, A Jimenez, S Haricharan Cancer Epidemiology, Biomarkers & Prevention 29 (12_Supplement), PO-090-PO-090, 2020 | | 2020 |
| Aloran Mazumder and Marc Diederich are supported by RSL (Luxemburg) and by the Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, by … A Mazumder Free Radicals and Diseases, 71, 2016 | | 2016 |
| Bcl-2 protein family expression pattern determines synergistic pro-apoptotic effects of BH3 mimetics with hemisynthetic cardiac glycoside UNBS1450 in acute myeloid leukemia C Cerella, A Gaigneaux, A Mazumder, JY Lee, E Saland, F Radogna, ... Leukemia 31 (3), 755-759, 2017 | 32 | 2017 |
| Caractérisation de l’alcaloïde bromé Isosulfarine-3 (Iso-3) un nouvel agent de déméthylation d’ADN: l’exemple de son effet antiprolifératif, proapoptotique et proautophagique … C Florean, M Schnekenburger, JY Lee, KR Kim, A Mazumder, S Song, ... Morphologie 102 (338), 146-147, 2018 | | 2018 |
| Cardiac glycoside glucoevatromonoside induces cancer type-specific cell death NFZ Schneider, C Cerella, JY Lee, A Mazumder, KR Kim, A De Carvalho, ... Frontiers in pharmacology 9, 70, 2018 | 39 | 2018 |
| Cardiac glycoside glucoevatromonoside induces cancer type-specific cell death. Front Pharmacol 9: 70–70 NFZ Schneider, C Cerella, JY Lee, A Mazumder, KR Kim, A de Carvalho, ... | 3 | 2018 |
| Differential impact of mutations in cell cycle checkpoint kinases on breast cancer presentation and prognosis S Seker, NB Punturi, S Carell, AM Mazumder, N Fusco, MN Bainbridge, ... bioRxiv, 2020.10. 29.361352, 2020 | | 2020 |
| Discovery and characterization of Isofistularin-3, a marine brominated alkaloid, as a new DNA demethylating agent inducing cell cycle arrest and sensitization to TRAIL in … C Florean, M Schnekenburger, JY Lee, KR Kim, A Mazumder, S Song, ... Oncotarget 7 (17), 24027, 2016 | 61 | 2016 |
| Discovery and Characterization of R/S-N-3-Cyanophenyl-N′-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)urea, a New … M Schnekenburger, E Goffin, JY Lee, JY Jang, A Mazumder, S Ji, ... Journal of medicinal chemistry 60 (11), 4714-4733, 2017 | 25 | 2017 |
| Dual inhibition of sirtuins 1 and 2: reprogramming metabolic energy dynamics in chronic myeloid leukemia as an immunogenic anticancer strategy M Schnekenburger, A Lorant, SR Gajulapalli, R Rajora, JY Lee, ... Cancer communications (London, England), 0 | | |
| Endocannabinoid Dysfunction in Human Disease: Neuro-Ocular DAGLA-related Syndrome (NODrS), a unique pediatric condition J Friedman, A Mazumder, D Ogasawara, R Abou Jamra, G Bernard, ... MOVEMENT DISORDERS 37, S294-S295, 2022 | | 2022 |
| Endocannabinoid dysfunction in neurological disease: neuro-ocular DAGLA-related syndrome MN Bainbridge, A Mazumder, D Ogasawara, R Abou Jamra, G Bernard, ... Brain 145 (10), 3383-3390, 2022 | 4 | 2022 |
| HER2 activation and endocrine treatment resistance in HER2-negative breast cancer A Mazumder, S Shiao, S Haricharan Endocrinology 162 (10), bqab153, 2021 | 18 | 2021 |
| Human telomerase reverse transcriptase depletion potentiates the growth-inhibitory activity of imatinib in chronic myeloid leukemia stem cells C Grandjenette, M Schnekenburger, A Gaigneaux, D Gerard, C Christov, ... Cancer Letters 469, 468-480, 2020 | 11 | 2020 |
